Camber Launches Generic Sustiva®
Piscataway, NJ, May 2, 2018– Camber Pharmaceuticals is pleased to announce the addition of Efavirenz Tablets to our growing portfolio of products.
Efavirenz tablets are the generic version of Sustiva®. Sustiva is used to treat HIV.
Efavirenz tablets are available in 600mg 30ct bottle.
Camber’s commitment to its customers is to bring the highest quality generic pharmaceuticals to the market and provide a level of excellence in service, supply and affordability.
If you would like more information about this topic, please contact Kirk Hessels at 732.529.0430 or email at [email protected]
Recent articles
- 28 New Generics in 2022 and Anticipates Record Number of Approvals in 2023
- Camber Pharmaceuticals Launches Generic Cambia®
- Camber Pharmaceuticals Launches Generic Kuvan® Tablets and Powder for Oral Solution
- Camber Pharmaceuticals Launches Generic Vimpat® Injection
- Camber Pharmaceuticals Launches Generic Naprosyn®
- Camber Pharmaceuticals Launches Generic Lamictal XR®